Skip to content

Long-term outcome of Moyamoya disease in a single high-volume center; treatment strategy based on cerebral hemodynamic measurements

Long-term outcome of Moyamoya disease in a single high-volume center; treatment strategy based on cerebral hemodynamic measurements - Longterm outcome of Moyamoya

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000035257
Enrollment
2000
Registered
2019-01-01
Start date
2019-03-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

None listed

Sponsors

Department of Neurosurgery, Tokyo Medical and Dental University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Moyamoya disease (and quasi-moyamoya disease)

Exclusion criteria

Exclusion criteria: refusal of the participant

Design outcomes

Primary

MeasureTime frame
Natural course of Moyamoya disease (pediatric and adult patients, surgery vs. observation) in terms of neurocognitive functions, social outcome, stroke events, mortality, etc.

Countries

Japan

Contacts

Public ContactShoko Hara

Tokyo Medical and Dental University Neurosurgery

nariai.nsrg@tmd.ac.jp+81358035266

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026